Tokyo Tape
Sign in
← Waqoo

Annual report

4937.TEDINET S100SIBJ
Period2022-10-01 → 2023-09-30
Filed2023-12-21
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 115
MetricValuePeriodScopeSource row
Revenue¥1.7bn2022-10-01 → 2023-09-30Cons.Net sales
Revenue¥2.7bn2021-10-01 → 2022-09-30Cons.Net sales
Operating income¥278m2022-10-01 → 2023-09-30Cons.Operating income
Operating income−¥40m2021-10-01 → 2022-09-30Cons.Operating income
Ordinary income¥288m2022-10-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥22m2021-10-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥34m2022-10-01 → 2023-09-30Cons.Income before income taxes
Profit before tax−¥22m2021-10-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥28m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥57m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥28m2022-10-01 → 2023-09-30Cons.Profit loss
Net income−¥57m2021-10-01 → 2022-09-30Cons.Profit loss
Total assets¥1.6bnat 2023-09-30Cons.Assets
Total assets¥1.6bnat 2022-09-30Cons.Assets
Total liabilities¥809mat 2023-09-30Cons.Liabilities
Total liabilities¥821mat 2022-09-30Cons.Liabilities
Net assets / equity¥773mat 2023-09-30Cons.Net assets
Net assets / equity¥743mat 2022-09-30Cons.Net assets
Net assets / equity¥801mat 2021-09-30dCons.Net assets
Cash and deposits¥1.3bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥906mat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥1.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥906mat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.0bnat 2021-09-30dCons.Cash and cash equivalents
Operating cash flow¥456m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥169m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥49m2022-10-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥176m2021-10-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥8m2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥129m2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥9.432022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-19.042021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥9.322022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
Net assets per share¥256.73at 2023-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥246.98at 2022-09-30Cons.Net assets per share (5-year summary)
Equity ratio48.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio47.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
ROE3.7%2022-10-01 → 2023-09-30Cons.Rate of return on equity (5-year summary)
Employees50at 2023-09-30Cons.Number of employees
Employees44at 2022-09-30Cons.Number of employees
Revenue¥1.7bn2022-10-01 → 2023-09-30StandaloneNet sales
Revenue¥2.7bn2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥4.7bn2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Revenue¥4.5bn2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Revenue¥3.4bn2018-10-01 → 2019-09-30dStandaloneNet sales (5-year summary)
Operating income¥252m2022-10-01 → 2023-09-30StandaloneOperating income
Operating income−¥40m2021-10-01 → 2022-09-30StandaloneOperating income
Ordinary income¥275m2022-10-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥21m2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥141m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥109m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥794m2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥34m2022-10-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥21m2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥32m2022-10-01 → 2023-09-30StandaloneProfit loss
Net income−¥57m2021-10-01 → 2022-09-30StandaloneProfit loss
Net income¥116m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Net income¥99m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income−¥795m2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Total assets¥1.6bnat 2023-09-30StandaloneAssets
Total assets¥1.6bnat 2022-09-30StandaloneAssets
Total assets¥1.9bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total assets¥1.2bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥1.0bnat 2019-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥802mat 2023-09-30StandaloneLiabilities
Total liabilities¥820mat 2022-09-30StandaloneLiabilities
Net assets / equity¥777mat 2023-09-30StandaloneNet assets
Net assets / equity¥743mat 2022-09-30StandaloneNet assets
Net assets / equity¥801mat 2021-09-30dStandaloneNet assets
Net assets / equity¥161mat 2020-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥63mat 2019-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.2bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥905mat 2022-09-30StandaloneCash and deposits
Cash & equivalents¥1.0bnat 2021-09-30dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥474mat 2020-09-30dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥399mat 2019-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥128m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥88m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥986m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥6m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥2m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥20m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥703m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥16m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥829m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥10.572022-10-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.952021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥41.612020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥36.452019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-324.742018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥10.442022-10-01 → 2023-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥40.92020-10-01 → 2021-09-30dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥257.96at 2023-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥247.07at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥266.72at 2021-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥59.61at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥23.16at 2019-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio49.2%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio47.5%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.1%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio13.7%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio6.3%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE4.2%2022-10-01 → 2023-09-30StandaloneRate of return on equity (5-year summary)
ROE24.1%2020-10-01 → 2021-09-30dStandaloneRate of return on equity (5-year summary)
ROE88.1%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued3,010,278at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,006,178at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,001,178at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,353,175at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued270,635at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees50at 2023-09-30StandaloneNumber of employees
Employees44at 2022-09-30StandaloneNumber of employees
Employees72at 2021-09-30dStandaloneNumber of employees
Employees59at 2020-09-30dStandaloneNumber of employees
Employees55at 2019-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingdepreciation2022-10-01 → 2023-09-30¥777,000
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-09-30−¥1m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-09-30−¥1m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-09-30−¥353m
Direct To Consumer Businessreportable segmentdepreciation2022-10-01 → 2023-09-30¥5m
Direct To Consumer Businessreportable segmentrevenue2022-10-01 → 2023-09-30¥1.6bn
Direct To Consumer Businessreportable segmentrevenue external2022-10-01 → 2023-09-30¥1.6bn
Direct To Consumer Businessreportable segmentrevenue intersegment2022-10-01 → 2023-09-30¥1m
Direct To Consumer Businessreportable segmentsegment profit2022-10-01 → 2023-09-30¥679m
Medical Supportreportable segmentrevenue2022-10-01 → 2023-09-30¥167m
Medical Supportreportable segmentrevenue external2022-10-01 → 2023-09-30¥167m
Medical Supportreportable segmentsegment profit2022-10-01 → 2023-09-30−¥48m
—segment totaldepreciation2022-10-01 → 2023-09-30¥5m
—segment totalrevenue2022-10-01 → 2023-09-30¥1.7bn
—segment totalrevenue external2022-10-01 → 2023-09-30¥1.7bn
—segment totalrevenue intersegment2022-10-01 → 2023-09-30¥1m
—segment totalsegment profit2022-10-01 → 2023-09-30¥631m
Reconciling Itemsreconcilingdepreciation2021-10-01 → 2022-09-30¥1m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-09-30−¥319m
Direct To Consumer Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥5m
Direct To Consumer Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥2.5bn
Direct To Consumer Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥2.5bn
Direct To Consumer Businessreportable segmentsegment profit2021-10-01 → 2022-09-30¥123m
Medical Supportreportable segmentrevenue2021-10-01 → 2022-09-30¥200m
Medical Supportreportable segmentrevenue external2021-10-01 → 2022-09-30¥200m
Medical Supportreportable segmentsegment profit2021-10-01 → 2022-09-30¥156m
—segment totaldepreciation2021-10-01 → 2022-09-30¥5m
—segment totalrevenue2021-10-01 → 2022-09-30¥2.7bn
—segment totalrevenue external2021-10-01 → 2022-09-30¥2.7bn
—segment totalsegment profit2021-10-01 → 2022-09-30¥279m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,180
ItemContextValueUnit
Repayment of long term loans payable fin cfCurrentYearDuration-209987000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration2500000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration2050000JPY
Purchase of treasury stock fin cfPrior1YearDuration－JPY
Purchase of treasury stock fin cfCurrentYearDuration-54000JPY
Net cash provided by used in financing activitiesPrior1YearDuration-129166000JPY
Net cash provided by used in financing activitiesCurrentYearDuration-7991000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration－JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration－JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration-136468000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration398800000JPY
Cash and cash equivalentsPrior2YearInstant1042693000JPY
Cash and cash equivalentsPrior1YearInstant906224000JPY
Cash and cash equivalentsPrior1YearInstant906224000JPY
Cash and cash equivalentsCurrentYearInstant1305025000JPY
Number of consolidated subsidiariesCurrentYearInstant1
Cost of sales notes regarding write downs of inventoriesPrior1YearDuration271664000JPY
Cost of sales notes regarding write downs of inventoriesCurrentYearDuration-22668000JPY
Payrolls and allowances etc sgaPrior1YearDuration363335000JPY
Payrolls and allowances etc sgaCurrentYearDuration307222000JPY
Advertising expenses sgaPrior1YearDuration768624000JPY
Advertising expenses sgaCurrentYearDuration94134000JPY
Freightage and packing expenses sgaPrior1YearDuration385320000JPY
Freightage and packing expenses sgaCurrentYearDuration223172000JPY
Sales commission sgaPrior1YearDuration218158000JPY
Sales commission sgaCurrentYearDuration116970000JPY
Depreciation sgaPrior1YearDuration6346000JPY
Depreciation sgaCurrentYearDuration6112000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember2531368000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember200008000JPY
Revenues from external customersPrior1YearDuration_ReportableSegmentsMember2731376000JPY
Revenues from external customersPrior1YearDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YearDuration2731376000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember－JPY
Transactions with other segmentsPrior1YearDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YearDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YearDuration－JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember2531368000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember200008000JPY
Net salesPrior1YearDuration_ReportableSegmentsMember2731368000JPY
Net salesPrior1YearDuration_ReconcilingItemsMember－JPY
Net salesPrior1YearDuration2731376000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember122956000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember156266000JPY
Operating incomePrior1YearDuration_ReportableSegmentsMember279223000JPY
Operating incomePrior1YearDuration_ReconcilingItemsMember-319002000JPY
Operating incomePrior1YearDuration-39779000JPY
Depreciation segment informationPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember5335000JPY
Depreciation segment informationPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
balance sheet identitynon_consolidated 2022-09-30pass
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-09-30pass
statement vs summary · revenueconsolidated 2021-10-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-10-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass